Cargando…

Recent advances in supramolecular antidotes

Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hang, Zhang, Xiangjun, Wei, Jianwen, Lu, Siyu, Bardelang, David, Wang, Ruibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738896/
https://www.ncbi.nlm.nih.gov/pubmed/33391548
http://dx.doi.org/10.7150/thno.53459
_version_ 1783623220846395392
author Yin, Hang
Zhang, Xiangjun
Wei, Jianwen
Lu, Siyu
Bardelang, David
Wang, Ruibing
author_facet Yin, Hang
Zhang, Xiangjun
Wei, Jianwen
Lu, Siyu
Bardelang, David
Wang, Ruibing
author_sort Yin, Hang
collection PubMed
description Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of a poison, and they are also used today to positively cancel the benefits of a poison after use. Currently, the majority of poisons are composed of small molecules. This review focuses on recent developments to reverse or prevent toxic effects of poisons by encapsulation in host molecules. Cyclodextrins, cucurbiturils, acyclic cucurbituril derivatives, calixarenes, and pillararenes, have been reported to largely impact the effects of toxic compounds, thus extending the current paradigm of small molecule antidotes by adding a new family of macrocyclic compounds to the current arsenal of antidotes. Along this line of research, endogenous "harmful" species are also sequestered by one or more of these supramolecular host molecules, expanding the potential of supramolecular antidotes to diverse therapeutic areas.
format Online
Article
Text
id pubmed-7738896
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-77388962021-01-01 Recent advances in supramolecular antidotes Yin, Hang Zhang, Xiangjun Wei, Jianwen Lu, Siyu Bardelang, David Wang, Ruibing Theranostics Review Poisons always have fascinated humankind. Initially considered as deleterious or hazardous substances, the modern era has witnessed the controlled utilization of dangerous poisons in medicine and cosmetics. Simultaneously, antidotes have become crucial as reversal agents to counteract the effects of a poison, and they are also used today to positively cancel the benefits of a poison after use. Currently, the majority of poisons are composed of small molecules. This review focuses on recent developments to reverse or prevent toxic effects of poisons by encapsulation in host molecules. Cyclodextrins, cucurbiturils, acyclic cucurbituril derivatives, calixarenes, and pillararenes, have been reported to largely impact the effects of toxic compounds, thus extending the current paradigm of small molecule antidotes by adding a new family of macrocyclic compounds to the current arsenal of antidotes. Along this line of research, endogenous "harmful" species are also sequestered by one or more of these supramolecular host molecules, expanding the potential of supramolecular antidotes to diverse therapeutic areas. Ivyspring International Publisher 2021-01-01 /pmc/articles/PMC7738896/ /pubmed/33391548 http://dx.doi.org/10.7150/thno.53459 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Yin, Hang
Zhang, Xiangjun
Wei, Jianwen
Lu, Siyu
Bardelang, David
Wang, Ruibing
Recent advances in supramolecular antidotes
title Recent advances in supramolecular antidotes
title_full Recent advances in supramolecular antidotes
title_fullStr Recent advances in supramolecular antidotes
title_full_unstemmed Recent advances in supramolecular antidotes
title_short Recent advances in supramolecular antidotes
title_sort recent advances in supramolecular antidotes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738896/
https://www.ncbi.nlm.nih.gov/pubmed/33391548
http://dx.doi.org/10.7150/thno.53459
work_keys_str_mv AT yinhang recentadvancesinsupramolecularantidotes
AT zhangxiangjun recentadvancesinsupramolecularantidotes
AT weijianwen recentadvancesinsupramolecularantidotes
AT lusiyu recentadvancesinsupramolecularantidotes
AT bardelangdavid recentadvancesinsupramolecularantidotes
AT wangruibing recentadvancesinsupramolecularantidotes